The Contract Research, Development and Manufacturing Organization (CRDMO) WuXi STA has begun construction on a site in Middletown, Delaware. The company expects it to be operational in 2025.
This 190-acre pharmaceutical manufacturing campus will be the company’s second U.S. site and the first on the East Coast.
The site will be based in the Middletown Business Center at 1091 Industrial Drive.
WuXi STA says it expects the new facility will create roughly 500 full-time jobs by 2026.
The first focus of the new site will be formulation development, clinical and commercial drug product manufacturing services.
The site will focus on manufacturing various oral and injectable dosage forms. It will also offer packaging, labeling, storage and distribution services for clinical trial materials and commercial drug products.
The facility is expected to provide new supply chain services in the U.S. for both domestic and international customers.Read more